| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 27.04B | 26.62B | 25.45B | 23.83B | 21.53B | 18.06B |
| Gross Profit | 14.61B | 14.36B | 13.55B | 12.34B | 10.87B | 9.62B |
| EBITDA | 13.92B | 11.07B | 12.99B | 12.41B | 10.79B | 10.25B |
| Net Income | 4.33B | 4.31B | 3.15B | 2.84B | 1.67B | 2.96B |
Balance Sheet | ||||||
| Total Assets | 57.80B | 56.94B | 56.33B | 55.26B | 56.41B | 49.82B |
| Cash, Cash Equivalents and Short-Term Investments | 5.87B | 5.88B | 5.69B | 5.04B | 4.74B | 9.80B |
| Total Debt | 16.74B | 28.59B | 15.61B | 16.03B | 17.80B | 12.91B |
| Total Liabilities | 33.38B | 32.96B | 29.92B | 29.24B | 31.01B | 24.71B |
| Stockholders Equity | 24.42B | 23.98B | 26.40B | 26.02B | 25.40B | 25.11B |
Cash Flow | ||||||
| Free Cash Flow | 9.05B | 8.90B | 7.78B | 7.92B | 4.43B | 4.62B |
| Operating Cash Flow | 13.61B | 13.44B | 12.33B | 12.42B | 9.16B | 9.91B |
| Investing Cash Flow | -3.13B | -3.56B | -4.95B | -4.68B | -8.35B | -6.52B |
| Financing Cash Flow | -9.30B | -9.53B | -7.20B | -7.21B | -3.49B | -735.37M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | $9.78B | 11.78 | 17.55% | 7.82% | 8.21% | 30.97% | |
66 Neutral | $20.25B | 16.39 | 9.28% | 5.03% | 10.34% | 17.26% | |
64 Neutral | $14.34B | 17.17 | 11.99% | 6.14% | -4.78% | -32.55% | |
62 Neutral | $13.12B | 54.71 | 3.00% | 5.02% | -7.08% | -73.85% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |